Close

Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at the AACR 2020

2020.06.19

Check out our virtual posters ! Available on our website and at the #AACR20 from June 22, 2020 at 9:00 AM EDT.

Development of a pharmacological platform to study in real time immune checkpoints signaling pathways: validation with therapeutics mAbs and small molecules (Poster #6308) presents the last generation of bioSens-All™ platform dedicated to the identification and characterization of immune checkpoint inhibitors.